Gynecological cancers: Bridging the gap between research and cure

Abstract

Approximately 1.5 million women suffer from gynecological malignancies every year. Around 60 % of these cancers are classified as rare in the European population. Because of their rarity, the management of these tumors requires specific approaches by the cancer community and national health systems. Effective international collaborations in the area of gynecological cancer are underway, thanks to various initiatives such as GYNOCARE and other Collaboration in Science and Technology (COST) Actions. This special issue of EJSO collects expert opinions on the ongoing research and treatment options in various types of gynecological malignancy.